Key Record Dates
ClinicalTrials.gov Identifier: | NCT06015035 |
---|---|
Brief Title: | Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer |
First Submitted : | August 17, 2023 |
First Submitted that Met QC Criteria : | August 27, 2023 |
First Posted : | August 29, 2023 |
Last Update Submitted that Met QC Criteria : | August 27, 2023 |
Last Update Posted : | August 29, 2023 |